... brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers ...
http://www.freshnews.com/news/821868/mylan-launches-generic-nor-q-d-tablets-0-35-mg-28-day-cycle-
http://www.freshnews.com/news/821868/mylan-launches-generic-nor-q-d-tablets-0-35-mg-28-day-cycle-
No comments:
Post a Comment